SEC Form 4 research
| Issuer | Denali Therapeutics Inc. |
|---|---|
| Tickers | DNLI, DNI |
| Reporting owners | 42 |
| Officers and directors | 9 |
| Last public filing | 2026-09-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-09 | 2026-09-04 | Chin Peter Scott | S | 1,654 | $22.29 | Not reported |
| 2026-09-04 | 2026-09-02 | Thornberry Nancy | S | 615 | $23.74 | Not reported |
| 2026-09-04 | 2026-09-02 | Thornberry Nancy | S | 10,824 | $22.85 | Not reported |
| 2026-09-03 | 2026-09-01 | Schuth Alexander O. | S | 2,768 | $23.44 | Not reported |
| 2026-08-13 | 2026-08-11 | Schuth Alexander O. | S | 2,857 | $25.07 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.